Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

BACKGROUND: Idiopathic membranous nephropathy (iMN) is recognized as an organ-specific autoimmune disease, mainly caused by anti-PLA2R antibody. This study aimed to study between anti-PLA2R antibody level at diagnosis and the response to tacrolimus (TAC)-based treatment in iMN patients. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bihua, Zhu, Zhidan, Huang, Feng, Huang, Haowen, Tu, Luxia, Wang, Ying, Zheng, Linfeng, Zhou, Jing, Wei, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450429/
https://www.ncbi.nlm.nih.gov/pubmed/36068486
http://dx.doi.org/10.1186/s12882-022-02914-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450429/
https://www.ncbi.nlm.nih.gov/pubmed/36068486
http://dx.doi.org/10.1186/s12882-022-02914-4

Ejemplares similares